3-Bromo-2-methylbenzoic acid

CAS : 76006-33-2

Ref. 3D-FB54359

Informations sur le produit

• Nom: 3-Bromo-2-methylbenzoic acid
• Marque: Biosynth
• Description: 3-Bromo-2-methylbenzoic acid is a hydrogen bond donor. Hydrogen bonding may provide an explanation for the functional theory of 3-bromo-2-methylbenzoic acid, which has been shown to have anticancer properties in vitro and in vivo. This compound has been shown to be effective against cancer cells that express PDL1 (programmed cell death protein 1) and is being studied as a potential therapeutic agent for cancers that are resistant to conventional anticancer drugs. 3-Bromo-2-methylbenzoic acid has low solubility in water and is poorly absorbed from the gastrointestinal tract. It also does not bind to plasma proteins, which makes it pharmacologically active even at low doses. 3BBMBA inhibits viral replication by binding to the viral RNA polymerase enzyme, thereby inhibiting transcription and replication of the virus genome. In addition, it inhibits the proliferation of human cancer cells through inhibition of protein synthesis and DNA synthesis

Propriétés chimiques

• Masse moléculaire: 215.04 g/mol
• Formule: C₈H₇BrO₂
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder
• InChI: InChI=1S/C8H7BrO2/c1-5-6(8(10)11)3-2-4-7(5)9/h2-4H,1H3,(H,10,11)
• Code InChI: InChIKey=BJGKVCKGUBYULR-UHFFFAOYSA-N
• SMILES: Cc1c(Br)cccc1C(=O)O